"Ophthalmologists, Retina Specialists Referrals, please fax (403) 286-6819"

During the past decade, Calgary Retina Consultants conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Calgary Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Allergan" with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Unity Health Toronto" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Calgary Retina Consultants" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (3 trials), "Macular Degeneration" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Calgary Retina Consultants" in a lesser frequency.

Most popular intervention types in "Calgary Retina Consultants" are "Drug" (9 trials), "Other" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (3 trials), "Sham" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calgary Retina Consultants" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Calgary Retina Consultants". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Calgary Retina Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Calgary Retina Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".